News
NOTTINGHAM, England, Sept. 21, 2023 /PRNewswire/ -- A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical ...
RESEARCH TRIANGLE PARK, N.C., October 25, 2024--Evecxia Therapeutics—the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback